ANA
LLUCH HERNANDEZ
EMÉRITO/A UNIVERSIDAD
Josep
Tabernero Caturla
Publications dans lesquelles il/elle collabore avec Josep Tabernero Caturla (4)
2015
-
Patterns of HER2 gene amplification and response to anti-HER2 therapies
PLoS ONE, Vol. 10, Núm. 6
2007
-
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer
Journal of Clinical Oncology, Vol. 25, Núm. 23, pp. 3399-3406
2005
-
Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer
Journal of Clinical Oncology, Vol. 23, Núm. 23, pp. 5323-5333
2004
-
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer
Annals of Oncology, Vol. 15, Núm. 9, pp. 1358-1365